Aelis Farma (XPAR:AELIS) E10: €0.00 (As of Dec. 2025)


XPAR:AELIS Aelis Farma SA XPAR:AELIS
32 GF Score
Price €1.05
GF Value €0.98
Valuation Fairly Valued
! 4 Warning Signs
View Full Analysis

What is Aelis Farma E10?

Aelis Farma XPAR:AELIS -2.23% 32 E10 is €0.00 as of Dec. 2025. GuruFocus rates XPAR:AELIS with a GF Score™ of 32/100 and a GF Value™ of €0.98 (Fairly Valued). The stock has 4 warning signs investors should review.

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller P/E calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years.

Aelis Farma's adjusted earnings per share data for the fiscal year that ended in Dec. 2025 was €-0.470. Add all the adjusted EPS for the past 10 years together and divide 10 will get our e10, which is €0.00 for the trailing ten years ended in Dec. 2025.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the E10 growth rate using E10 data.

As of today (2026-07-11), Aelis Farma's current stock price is € 1.05. Aelis Farma's E10 for the fiscal year that ended in Dec. 2025 was €0.00. Aelis Farma's Shiller PE Ratio of today is .


Aelis Farma  (XPAR:AELIS) E10 Explanation

If a company grows much fast than inflation, E10 may underestimate the company's earnings power. Shiller PE Ratio can seem to be too high even the actual P/E is low.

For the Shiller P/E, the earnings of the past 10 years are inflation-adjusted and averaged. The result is used for P/E calculation. Since it looks at the average over the last 10 years, the Shiller P/E is also called PE10.

The Shiller P/E was first used by professor Robert Shiller to measure the valuation of the overall market. The same calculation is applied here to individual companies.


Be Aware

Shiller PE Ratio works better for cyclical companies. It gives you a better idea on the company's real earnings power.


Aelis Farma E10 Related Terms


Aelis Farma E10 Historical Data

* Premium members only.

The historical data trend for Aelis Farma's E10 can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Aelis Farma E10 Chart

Aelis Farma Annual Data
Trend Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
E10
Get a 7-Day Free Trial Premium Member Only 0.00 0.00 0.00 0.00 0.00

Aelis Farma Semi-Annual Data
Dec17 Dec18 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24 Jun25 Dec25
E10 Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00

XPAR:AELIS vs VRTX, REGN, ALNY: E10 Comparison

For the Biotechnology subindustry, Aelis Farma's Shiller PE Ratio, along with its competitors' market caps and Shiller PE Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Aelis Farma Shiller PE Ratio vs Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Aelis Farma's Shiller PE Ratio distribution charts can be found below:

* The bar in red indicates where Aelis Farma's Shiller PE Ratio falls into.


XPAR:AELIS
32GF Score
Aelis Farma SA XPAR:AELIS
E10 is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Aelis Farma E10 Calculation

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller P/E calculation. When we calculate the today's Shiller P/E ratio of a stock, we use today's price divided by E10.

What is E10? How do we calculate E10?

E10 is the average of the inflation adjusted earnings of a company over the past 10 years. Let's use an example to explain.

If we want to calculate the E10 of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the earnings from 2001 through 2010.

We adjusted the earnings of 2001 earnings data with the total inflation from 2001 through 2010 to the equivalent earnings in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart earned $1 a share in 2001, then the 2001's equivalent earnings in 2010 is $1.4 a share. If Wal-Mart earns $1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 earnings in 2010 is $1.35. So on and so forth, you get the equivalent earnings of past 10 years. Then you add them together and divided the sum by 10 to get E10.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

For example, Aelis Farma's adjusted earnings per share data for the fiscal year that ended in Dec. 2025 was:

Adj_EPS=Earnings per Share (Diluted) /CPI of Dec. 2025 (Change)*Current CPI (Dec. 2025)
=-0.47/120.9000*120.9000
=-0.470

Current CPI (Dec. 2025) = 120.9000.

Aelis Farma does not have a history long enough to calculate E10. Therefore GuruFocus does not calculate it.

Frequently Asked Questions Learn more about E10 →
What does a E10 of €0.00 mean?
Aelis Farma (XPAR:AELIS) has a E10 of €0.00 as of Dec. 2025. E10 represents the company's inflation-adjusted earnings per share over a 10-year period. View historical data on Aelis Farma and its competitors.
Is Aelis Farma's E10 too high?
Aelis Farma's current E10 is €0.00. Overall, Aelis Farma has a GF Score™ of 32/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does Aelis Farma's E10 compare to VRTX and REGN?
Aelis Farma's E10 of €0.00 can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good E10 for a Biotechnology company?
A good E10 depends on the Biotechnology industry context. However, E10 should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high E10 mean?
A high E10 can signal that a stock is expensive relative to its fundamentals. E10 represents the company's inflation-adjusted earnings per share over a 10-year period. View historical data on Aelis Farma and its competitors. Aelis Farma's current E10 is €0.00. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Aelis Farma stock overvalued right now?
Based on GuruFocus' analysis, Aelis Farma (XPAR:AELIS) is currently considered Fairly Valued. The stock's GF Value™ is €0.98, compared to a current price of €1.05 — trading 7.1% above its estimated fair value. The current E10 is €0.00. Aelis Farma's overall GF Score™ is 32/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is E10 calculated?
E10 is calculated from a company's financial statements. For Aelis Farma (XPAR:AELIS), the current E10 is €0.00 as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Aelis Farma (XPAR:AELIS) Overvalued in 2026?

Based on GuruFocus' analysis, Aelis Farma stock appears to be overvalued. The current stock price of €1.05 is trading 7.1% above its estimated GF Value™ of €0.98. GuruFocus considers Aelis Farma to be Fairly Valued.

Key valuation signals for XPAR:AELIS:

  • E10: €0.00
  • GF Value™: €0.98 vs. price of €1.05 (7.1% above fair value)
  • GF Score™: 32/100 with 4 warning signs

No single metric tells the full story. See the XPAR:AELIS stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Aelis Farma Business Description

Other Exchanges 69O:Germany
Address 2 rue Robert Escarpit, IECB, Pessac, Bordeaux, FRA, 33607
Aelis Farma SA is a biotechnology Company specializing in the research and development of treatment's related to brain diseases. The Company operates in only one business segment: the research and development of pharmaceutical products.
32GF Score

Get the complete analysis for XPAR:AELIS

E10 is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€1.05
Price
€0.98
GF Value